High non-cardiac death incidence should be a limitation of drug-eluting stents implantation? insights from recent randomized data

HIGHLIGHTS

• who: Alfredo E. Rodriguez and colleagues from the Center (CECI), Buenos Aires, Argentina have published the research: High Non-Cardiac Death Incidence Should Be a Limitation of Drug-Eluting Stents Implantation? Insights from Recent Randomized Data, in the Journal: Diagnostics 2023, 13, x FOR PEER REVIEW of 18/Nov/2019
• what: Until all these issues are resolved the authors propose that DES implantation should be tailored accorded patient age life expectancy and lesion complexity. It was only recently that major landmarks in randomized clinical trials (RCT) reported at long-term follow-up either an unexpected . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.